Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

United Neuroscience To Move Forward Alzheimer's Vaccine After Promising Phase IIa

17 Jan 2019

• By Emily Hayes

Related Content

United Neuroscience Hopes To Revive Vaccine Approach To Alzheimer’s

24 Sep 2018

Wyeth/Elan Submit Pharmacogenomics Study Report From Alzheimer’s Trial To FDA

18 Mar 2004

M&A Pressure Mounts For Merck & Co After Alzheimer's Drug Dismissed

14 Feb 2018

Lilly’s Solanezumab Fails, But The Surprise Would Have Been Success

23 Nov 2016

Biogen's Busy Pipeline: Continued Confusion On BAN2401, But Other Irons In The Fire

26 Oct 2018

Related Companies

Perrigo Company PLC

Pfizer Inc.

Johnson & Johnson

Eli Lilly and Company

AstraZeneca PLC

Merck & Co., Inc.

Biogen, Inc.

Additional Topics

Clinical Trials Research & Development Neurology BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.